Lactobacillus helveticus SBT2171 attenuates experimental autoimmune encephalomyelitis in mice

Frontiers in Microbiology

Volumn 8, Issue JAN, 2018, Pages

  Yamashita, Maya ^a   Ukibe, Ken ^a   Matsubara, Yumi ^b   Hosoya, Tomohiro ^a   Sakai, Fumihiko ^a   Kon, Shigeyuki ^c   Arima, Yasunobu ^b   Murakami, Masaaki ^b   Nakagawa, Hisako ^b   Miyazaki, Tadaaki ^b  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Experimental autoimmune encephalomyelitis; Interleukin 6; Lactobacillus helveticus SBT2171; Multiple sclerosis; Th17 cells

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 6;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNIZATION; LACTOBACILLUS HELVETICUS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 85040835882     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.02596     Document Type: Article

References (45)

1. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., et al. (2007). Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646
2. Amdekar, S., Singh, V., Singh, R., Sharma, P., Keshav, P., and Kumar, A. (2011). Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J. Clin. Immunol. 31, 147-154. doi: 10.1007/s10875-010-9457-7
3. Arima, Y., Harada, M., Kamimura, D., Park, J. H., Kawano, F., Yull, F. E., et al. (2012). Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148, 447-457. doi: 10.1016/j.cell.2012.01.022
4. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., et al. (2011). Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538-541. doi: 10.1038/nature10554
5. Bhat, R., and Steinman, L. (2009). Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64, 123-132. doi: 10.1016/j.neuron.2009.09.015
6. Brownlee, W. J., Hardy, T. A., Fazekas, F., and Miller, D. H. (2017). Diagnosis of multiple sclerosis: progress and challenges. Lancet 389, 1336-1346. doi: 10.1016/S0140-6736(16)30959-X
7. Cheng, W., and Chen, G. (2014). Chemokines and chemokine receptors in multiple sclerosis. Mediators Inflamm. 2014:659206. doi: 10.1155/2014/659206
8. Compston, A., and Coles, A. (2002). Multiple sclerosis. Lancet 359, 1221-1231
9. Domingues, H. S., Mues, M., Lassmann, H., Wekerle, H., and Krishnamoorthy, G. (2010). Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLOS ONE 5:e15531. doi: 10.1371/journal.pone.0015531
10. Gaffen, S. L., Jain, R., Garg, A. V., and Cua, D. J. (2014). The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585-600. doi: 10.1038/nri3707
11. Gensicke, H., Leppert, D., Yaldizli, ö, Lindberg, R. L., Mehling, M., Kappos, L., et al. (2012). Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis. CNS Drugs 26, 11-37. doi: 10.2165/11596920-000000000-00000
12. Goverman, J. (2009). Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407. doi: 10.1038/nri2550
13. Greer, J. M., Sobel, R. A., Sette, A., Southwood, S., Lees, M. B., and Kuchroo, V. K. (1996). Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156, 371-379
14. Griet, M., Zelaya, H., Mateos, M. V., Salva, S., Juarez, G. E., de Valdez, G. F., et al. (2014). Soluble factors from Lactobacillus reuteri CRL1098 have anti-inflammatory effects in acute lung injury induced by lipopolysaccharide in mice. PLOS ONE 9:e110027. doi: 10.1371/journal.pone.0110027
15. Hosoya, T., Sakai, F., Yamashita, M., Shiozaki, T., Endo, T., Ukibe, K., et al. (2014). Lactobacillus helveticus SBT2171 inhibits lymphocyte proliferation by regulation of the JNK signaling pathway. PLOS ONE 9:e108360. doi: 10.1371/journal.pone.0108360
16. Ito, K., Morimoto, J., Kihara, A., Matsui, Y., Kurotaki, D., Kanayama, M., et al. (2014). Integrin a9 on lymphatic endothelial cells regulates lymphocyte egress. Proc. Natl. Acad. Sci. U.S.A. 111, 3080-3085. doi: 10.1073/pnas.1311022111
17. Ivory, K., Chambers, S. J., Pin, C., Prieto, E., Arqués, J. L., and Nicoletti, C. (2008). Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin. Exp. Allergy 38, 1282-1289. doi: 10.1111/j.1365-2222.2008.03025.x
18. Kato, I., Endo-Tanaka, K., and Yokokura, T. (1998). Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci. 63, 635-644
19. Kohler, R. E., Caon, A. C., Willenborg, D. O., Clark-Lewis, I., and McColl, S. R. (2003). A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170, 6298-6306
20. Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., et al. (2010). A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLOS ONE 5:e9009. doi: 10.1371/journal.pone.0009009
21. Lee, J. M., and Han, M. H. (2015). Patient experience and practice trends in multiple sclerosis-clinical utility of fingolimod. Patient Prefer. Adherence 9, 685-693. doi: 10.2147/PPA.S57354
22. Leung, S., Liu, X., Fang, L., Chen, X., Guo, T., and Zhang, J. (2010). The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell. Mol. Immunol. 7, 182-189. doi: 10.1038/cmi.2010.22
23. Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., et al. (2015). Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV Clusters. PLOS ONE 10:e0137429. doi: 10.1371/journal.pone.0137429
24. Miyazaki, T. (2015). 'Efficacy of Probiotics in Prevention of Influenza,' in Beneficial Microorganisms in Medical and Health Applications. Microbiology Monographs, Vol. 28, ed. M. T. Liong (Cham: Springer)
25. Nakayama, Y., Moriya, T., Sakai, F., Ikeda, N., Shiozaki, T., Hosoya, T., et al. (2014). Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci. Rep. 4:4638. doi: 10.1038/srep04638
26. Nalbant, A., and Eskier, D. (2016). Genes associated with T helper 17 cell differentiation and function. Front. Biosci. 8, 427-435. doi: 10.2741/e777
27. Nishihira, J., Moriya, T., Sakai, F., Kabuki, T., Kawasaki, Y., and Nishimura, M. (2016). Lactobacillus gasseri SBT2055 stimulates immunoglobulin production and innate immunity after influenza vaccination in healthy adult volunteers. Funct. Foods Health Dis. 6, 544-568
28. Nishikawa, T., Terabe, F., Ohkawara, T., Takahashi, T., Ripley, B., Kimura, A., et al. (2008). IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 105, 9041-9046. doi: 10.1073/pnas.0802218105
29. Novotny Núñez, I., Maldonado Galdeano, C., de Moreno de LeBlanc, A., and Perdigón, G. (2015). Lactobacillus casei CRL 431 administration decreases inflammatory cytokines in a diet-induced obese mouse model. Nutrition 31, 1000-1007. doi: 10.1016/j.nut.2015.02.006
30. Ontaneda, D., Thompson, A. J., Fox, R. J., and Cohen, J. A. (2017). Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet 389, 1357-1366. doi: 10.1016/S0140-6736(16)31320-4
31. Ransohoff, R. M., and Brown, M. A. (2012). Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164-1171. doi: 10.1172/JCI58644
32. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., et al. (2009). C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514-523. doi: 10.1038/ni.1716
33. Ryu, C. H., Park, K. Y., Hou, Y., Jeong, C. H., Kim, S. M., and Jeun, S. S. (2013). Gene therapy of multiple sclerosis using interferon β-secreting human bone marrow mesenchymal stem cells. Biomed Res. Int. 2013:696738. doi: 10.1155/2013/696738
34. Sasaki, M., Bosman, B. W., and Tan, P. S. (1996). A new, broad-substrate-specificity aminopeptidase from the dairy organism Lactobacillus helveticus SBT 2171. Microbiology 142, 799-808
35. Segal, B. M. (2010). Th17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 32, 71-77. doi: 10.1007/s00281-009-0186-z
36. Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., et al. (2016). Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates immunoglobulin levels and cytokines expression in whey proteins sensitised mice. J. Sci. Food Agric. 96, 3180-3187. doi: 10.1002/jsfa.7497
37. Shida, K., Takahashi, R., Iwadate, E., Takamizawa, K., Yasui, H., Sato, T., et al. (2002). Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 32, 563-570. doi: 10.1046/j.0954-7894.2002.01354.x
38. So, J. S., Lee, C. G., Kwon, H. K., Yi, H. J., Chae, C. S., Park, J. A., et al. (2008). Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol. Immunol. 46, 172-180. doi: 10.1016/j.molimm.2008.07.038
39. Stromnes, I. M., and Goverman, J. M. (2006). Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1, 1810-1819
40. Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J. A., et al. (2011). The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLOS ONE 6:e27644. doi: 10.1371/journal.pone.0027644
41. Waki, N., Yajima, N., Suganuma, H., Buddle, B. M., Luo, D., Heiser, A., et al. (2014). Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection. Lett. Appl. Microbiol. 58, 87-93. doi: 10.1111/lam.12160
42. Yamamoto, K., Yokoyama, K., Matsukawa, T., Kato, S., Kato, S., Yamada, K., et al. (2016). Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. J. Dairy Sci. 99, 5039-5046. doi: 10.3168/jds.2015-10605
43. Yamashita, M., Matsumoto, K., Endo, T., Ukibe, K., Hosoya, T., Matsubara, Y., et al. (2017). Preventive effect of Lactobacillus helveticus SBT2171 on collagen-induced arthritis in mice. Front. Microbiol. 8:1159. doi: 10.3389/fmicb.2017.01159
44. Yamashita, M., Ukibe, K., Uenishi, H., Hosoya, T., Sakai, F., and Kadooka, Y. (2014). Lactobacillus helveticus SBT2171, a cheese starter, regulates proliferation and cytokine production of immune cells. J. Dairy Sci. 97, 4772-4779. doi: 10.3168/jds.2014-8041
45. Zhang, X., Koldzic, D. N., Izikson, L., Reddy, J., Nazareno, R. F., Sakaguchi, S., et al. (2004). IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16, 249-256